Dr. Mehmet Oz, the daytime television host Donald Trump has picked to run the Centers for Medicare and Medicaid Services (CMS), may have a direct financial stake in three companies that would do business with the agency he intends to run.

A review of Oz’s 2022 tax disclosure by Accountable.US revealed that the Trump ally owned up to $26 million stake in Sharecare, a digital health company co-founded by Oz that operates CareLinx, the “exclusive in-home care supplemental benefit program” used by 1.5 million Medicare Advantage enrollees. The company went private in 2024, so it’s unknown whether Oz still owns a stake in the company.

Novo Nordisk, which produces Ozempic and Wegovy among other drugs, is also a client of Sharecare. As head of CMS, Oz has considerable impact on the pharmaceutical industry—but with business ties like these, it’s equally likely that these drug companies could have a profound impact on him.

Oz’s transition team spokesperson, Nick Clemens, told USA Today Friday that Oz had sold off his stake in Sharecare, but did not speak […]